Oktenisept solution is applied:

• for the numerous processing of mucous membranes and surrounding skin limited in time before diagnostic and surgical procedures in anogenitalny area: vaginas, vulvas, a balanus, before bladder catheterization for processing of an oral cavity;
• for antiseptic treatment of local bacterial and fungal infections in vaginal area;
• for the maintenance therapy of mycosis of interdigital intervals limited in time and for antiseptic processing of wounds and burns of various origin.

Structure

100 g of solution contain (active ingredients):

• an oktenidin of dihydrochloride - 0.10 g;
phenoxyethanol
• 2 - 2.00 g

Excipients: cocamidopropyl betaine, sodium a gluconate, glycerin of 85%, sodium hydroxide, water purified.

Contraindication

• hypersensitivity to active agents or to any of medicament excipients;
not to apply
• in a nose, to washing of an abdominal cavity (for example, during operation), in a tympanic membrane and to instillation in a bladder.

Route of administration

Use for treatment of local bacterial and fungal infections in vaginal area is limited to adults and children aged from 8 years. According to all other indications of "Oktenisept" can apply adults and children without age restrictions.

only for topical administration and should not be entered into fabrics, for example by means of the syringe.

"Oktenisept" is applied undiluted, applying on affected areas before full moistening.

to Carry out further procedures, for example to apply a surgical bandage, it is possible at least in two minutes after medicament use. Rinsing of an oral cavity is also possible, but this route of administration is limited to cases when it is necessary to process all oral cavity. In that case it is necessary to apply 20 ml of medicament within 20 seconds.

For maintenance therapy in cases of mycosis of interdigital intervals medicine should be sprayed on affected areas in the morning and in the evening.

Treatment of local bacterial and fungal infections of the vaginal site

Before the first use extend the applicator from packing and place it on a bottle after removal of a transparent protective cover and a head of the spray. The mechanism of dispersion can work at the maintenance of a bottle in different provisions (vertically or turned down). For input of the applicator deeply in a vagina it is recommended to sit on a toilet bowl or to lie in a bed. Press a forefinger a cover of the applicator of 10 times for medicament distribution deeply in a vagina. After use wipe the applicator and press time spray one or two, directing the applicator down, for example over a sink. Duration of treatment has to be 7 days, in the first day to use medicament in the morning and in the evening, and then - 1 time a day in the evening. Before the following use press time spray one or two, directing the applicator down, and carry out the procedure as it is described. The applicator can be used during all course of treatment. After completion of treatment of a vaginal infection the applicator should be utilized.

For achievement of desirable effect needs to follow these instructions carefully.

As experience of continuous use makes no more than 14 days, "Oktenisept" should be applied during the limited term of treatment.

Moderate amount of the data obtained at pregnant women (from 300 to 1000 results of pregnancy, gestation term ≥ 12 weeks) indicates

Feature of use

lack of influence of Oktenisept solution on development of congenital anomalies and its toxicity on an embryo/fruit. Researches on animals did not reveal signs of reproductive toxicity. If necessary it is possible to apply "Oktenisept" during pregnancy. As clinical data for the first 3 months of pregnancy are absent, as a precautionary measure it is not necessary to use solution the medicament "Oktenisept" in the first 3 months of pregnancy.

Exhaustive data on use of medicament in the period of a lactation of pilot studies on animal and clinical trials are absent. As the oktenidina dihydrochloride is soaked up in very small amount or not soaked up absolutely, it is supposed that it does not get to breast milk. Fenoksietanol quickly and almost is completely soaked up, and brought almost completely in the form of the oxidized product by kidneys. Therefore its accumulation in breast milk is improbable. As a precautionary measure, "Oktenisept" should not be applied on the site of mammary glands during feeding with a breast.

Children

Dosage of Oktenisept solution is identical to

for adults and children.

Drivers

Drug does not influence speed of response at control of motor transport or work with other mechanisms.

Overdose

Data on overdose are absent. However at topical administration overdose probability very low. In case of local overdose the affected area can be washed out a large amount of Ringera solution.

cannot consider Accidental ingestion of Oktenisept solution dangerous. Oktenidina dihydrochloride is not soaked up and brought with a stake. In case of reception of hit in a large amount of Oktenisept solution it is impossible to exclude irritation of a mucous membrane of digestive tract.

dihydrochloride is more toxic after intravenous administration in comparison with peroral. Therefore it is necessary to avoid hit of a large amount of this solution in a blood stream, for example as a result of a wrong injection. However as this solution supports an oktenidin dihydrochloride in concentration of only 0.1%, developing of intoxication is very improbable.

Side effects

General disturbances and reactions in the site of application: seldom (from ≥ 1/10000 to <1/1000) - burning, reddening, an itching, caumesthesia in the place of use.

from skin and hypodermic fabrics: very seldom (<1/10000) - allergic contact reaction, for example temporary reddening in the place of use.

from a musculoskeletal system and connective tissue: frequency is unknown (it cannot be estimated on the basis of the available data) - after washing of deep wounds by means of the syringe the persistent hypostasis, an erythema and also necrosis of fabrics were observed, in certain cases demanded surgical audit.

.

following side effects Can meet: hypostasis, an induration, pain, blisters, eczema in a scope.

to Store

at a temperature not above 25 °C, in protected from light and the place, inaccessible for children.

Expiration date - 3 years.